首页> 美国卫生研究院文献>Nephron. Clinical Practice >Intestinal Microbiota-Kidney Cross Talk in Acute Kidney Injury and Chronic Kidney Disease
【2h】

Intestinal Microbiota-Kidney Cross Talk in Acute Kidney Injury and Chronic Kidney Disease

机译:肠道菌群-肾脏交叉交谈在急性肾脏损伤和慢性肾脏疾病中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The pathophysiology of acute kidney injury (AKI) involves multiple and overlapping immunological, biochemical, and hemodynamic mechanisms that modulate the effects of both the initial insult and the subsequent repair. Limited but recent experimental data have revealed that the intestinal microbiota significantly affects outcomes in AKI. Additional evidence shows significant changes in the intestinal microbiota in chronic kidney disease patients and in experimental AKI. In this minireview, we discuss the current status of the effect of intestinal microbiota on kidney diseases, the immunomodulatory effects of intestinal microbiota, and the potential mechanisms by which microbiota can modify kidney diseases and vice versa. We also propose future studies to clarify the role of intestinal microbiota in kidney diseases and to explore how the modification of gut microbiota may be a potential therapeutic tool.
机译:急性肾损伤(AKI)的病理生理学涉及多种和重叠的免疫,生化和血液动力学机制,这些机制可调节初始损伤和后续修复的作用。有限但近期的实验数据表明,肠道菌群会显着影响AKI的预后。其他证据表明,慢性肾脏病患者和实验性AKI的肠道菌群发生了显着变化。在此小型审查中,我们讨论了肠道菌群对肾脏疾病的作用的现状,肠道菌群的免疫调节作用以及微生物菌群改变肾脏疾病的潜在机制,反之亦然。我们还提出了未来的研究,以阐明肠道菌群在肾脏疾病中的作用,并探讨肠道菌群的修饰如何可能成为潜在的治疗工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号